Close Icon
Press Release September 25, 2017

Comprehend Presents Clinical Intelligence for Data-Driven Decisions

Comprehend Presentations and Booth Demos at SCDM 2017 Highlight Expertise Across Evolving Study, Portfolio and CRO Data

Comprehend, the leader in Clinical Intelligence software, will be presenting multiple case studies, presentations and demonstrations at SCDM 2017, held September 24-27, 2017 in Orlando. In response to an increasing demand from data managers, medical review teams and CRO partners for more automated capabilities across evolving data, Comprehend delivers real-time visualization, reporting and workflows for data integrated across portfolios, studies, systems and CROs. The result is reduced time, effort and complexity for effective data analysis and speed to insights and action.

“With changes in regulations, an increased focus on therapeutic treatments and constantly changing environments, pharmaceuticals and biotech companies are at risk of significant data delays,” said Rick Morrison, CEO of Comprehend. “We’re focused on enabling a faster, more reliable method of managing clinical trials, helping data management teams see and respond to real-time trends, outliers and issues before they reach criticality.”

Data management and medical review teams can learn more about these solutions at the following sessions:

Comprehend Exhibit Booth #608 – including demonstrations of self-service analytics, personalized dashboards, centralized monitoring, graphical patient profiles, dynamic line listings and CRO oversight. Stop by and “Spin the Wheel” to win gifts.

Panel Discussion, “Bridging the Clinical-Data Divide to Empower Sites, Monitors & Data Managers” 

Speaker: Rick Morrison, CEO, Comprehend Systems

Monday, September 25, 2017 at 10:45am ET

This presentation provides a strategic look at how data management has transformed over the years and what a “fully engaged” team will look like in the future.

Session: SDV – What is it good for? Absolutely Nothing!

Presentation, “Using Clinical Intelligence to Execute Centralized Monitoring in Evolving Operations” 

Speaker: Kenneth Wu, MS, MBA, of Kenneth Wu and Associates LLC

Tuesday, September 26, 2017 at 8:30am ET

This presentation will provide a case study example of how automation has enabled a pharmaceutical manufacturer to improve productivity, decrease investigation time and reduce risk through real-time analysis, monitoring and tasks on safety concerns

Session: Fail-Safe Central Data Monitoring in RBM – How Do We Achieve It?

Presentation, “The Race is On…Clinical Intelligence Helps Speed Oncology Drugs to Market” 

Speaker: Jud Gardner, CTO, Comprehend Systems

Tuesday, September 26,, 2017 at 10:45am ET

Jud Gardner presents an interesting case study of how a leading pharmaceutical was able to speed both access to data and insightful results to help data managers successfully support the delivery of a new drug to market.

Session: Improving Efficiency and Effectiveness in Data Management of Oncology Studies

In addition, session attendees who stop by the booth can receive a copy of Comprehend’s CRO Oversight Benchmark Report. Comprehend surveyed more than 100 leading life sciences leaders to deliver insight into Sponsor goals, challenges and best practices for continuous CRO oversight. The downloadable report covers how program, study and vendor oversight teams are approaching data management to address ICH E6 (R2), best practices for Quality Agreements and Oversight Plans, and a roadmap to continuous CRO Oversight.


About Comprehend Systems, Inc.

Comprehend, the leader in Clinical Intelligence solutions, is focused on accelerating treatments to patients. Our suite of software applications provide clinical operations, data management and medical review teams with the critical insights and automation they need to improve the speed, safety and quality of their clinical trials. Designed to unify, monitor and analyze clinical data across disparate sources in real-time, Comprehend’s Cloud software delivers solutions for CRO oversight, centralized monitoring, risk monitoring, data review and medical monitoring. Comprehend’s investors include Sequoia Capital, Lightspeed Venture Partners and Eminence Capital. Learn more at www.saama.com.

Media Contact

media@saama.com

Saama can put you on the fast track to clinical trial process innovation.